Originally described as mutated in the context of neurofibromatosis and tumors of the nervous system, Merlin has more recently been demonstrated to function as a tumor suppressor in mesothelioma, melanoma, and breast cancer1, 2, 3, 4, 5, 6. Here, NF2 is linked to neoplasm.